The product is enteric-coated capsules with each capsulecontaining 150mg of pancreatin. It belongs to OTC (Class B). It is indicatedfor dyspepsia, gastricism caused by pancreatic diseases, and it is also used asreplacement therapy for pancreatic exocrine insufficiency caused by variousfactors.
Pancreatin Enteric Capsules are pharmaceutical formulations containing a mixture of enzymes derived from porcine pancreas, specifically amylase, protease, and lipase. Manufactured via spray-drying or granulation with enteric coating to ensure stability in gastric acid, these capsules typically feature CAS numbers for individual components: 9001-56-7 (Amylase), 9004-02-0 (Protease), and 9001-68-1 (Lipase).
Contraindicated in patients with acute pancreatitis or hypersensitivity to pork proteins. Store below 25°C in dry conditions to prevent enzyme degradation. Avoid inhalation of powder dust during manufacturing to mitigate respiratory sensitization risks.